Detalhe da pesquisa
1.
The prognostic and predictive value of sstr2-immunohistochemistry and sstr2-targeted imaging in neuroendocrine tumors.
Eur J Nucl Med Mol Imaging
; 44(3): 468-475, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27539020
2.
Somatostatin Receptor-Targeted Radiopeptide Therapy in Treatment-Refractory Meningioma: Individual Patient Data Meta-analysis.
J Nucl Med
; 62(4): 507-513, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32859705
3.
Technical Note: Determination of individual thyroid clearance effective half-life with a common handheld electronic dosimeter.
Med Phys
; 44(4): 1558-1562, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28206679
4.
Diabetes Mellitus and Its Effects on All-Cause Mortality After Radiopeptide Therapy for Neuroendocrine Tumors.
J Nucl Med
; 58(1): 97-102, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27635023
5.
Reply: Diabetes Mellitus and Its Effects on All-Cause Mortality After Radiopeptide Therapy for Neuroendocrine Tumors: Methodologic Issues.
J Nucl Med
; 58(9): 1532, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28280219